News on BioWorld Today from BioPortfolio.com http://www.BioPortfolio.com Consolidated BioWorld Today news from BioPortfolio.com Wed, 10 Feb 2010 11:32:44 GMT en Activist Investor Pushes Celera to Divest Merck Bone Drug Royaltieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040410&HITNO=0&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040410&THISHREF=http://c.moreover.com/click/here.pl%3fz2538725899%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040410&HITNO=0&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040410&THISHREF=http://c.moreover.com/click/here.pl%3fz2538725899%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioWorld: Activist Investor Pushes Celera to Divest Merck Bone Drug Royaltieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039489&HITNO=1&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039489&THISHREF=http://c.moreover.com/click/here.pl%3fz2538152182%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039489&HITNO=1&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039489&THISHREF=http://c.moreover.com/click/here.pl%3fz2538152182%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: D-Mab Ascending Bone Throne: Phase III Strong in Prostate, toohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039485&HITNO=2&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039485&THISHREF=http://c.moreover.com/click/here.pl%3fz2538147883%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039485&HITNO=2&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039485&THISHREF=http://c.moreover.com/click/here.pl%3fz2538147883%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Abridged Study to Haunt CTI? FDA Questions Pixantrone Datahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033703&HITNO=3&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033703&THISHREF=http://c.moreover.com/click/here.pl%3fz2535347496%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033703&HITNO=3&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033703&THISHREF=http://c.moreover.com/click/here.pl%3fz2535347496%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioWorld: Abridged Study to Haunt CTI? FDA Questions Pixantrone Datahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032885&HITNO=4&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032885&THISHREF=http://c.moreover.com/click/here.pl%3fz2534848066%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032885&HITNO=4&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032885&THISHREF=http://c.moreover.com/click/here.pl%3fz2534848066%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: IPO Hopeful Anthera Gets SPA on Pivotal CV Outcomes Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032884&HITNO=5&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032884&THISHREF=http://c.moreover.com/click/here.pl%3fz2534847844%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032884&HITNO=5&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032884&THISHREF=http://c.moreover.com/click/here.pl%3fz2534847844%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Building Bones Complementary Approach in Osteoporosis Fighthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032743&HITNO=6&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032743&THISHREF=http://c.moreover.com/click/here.pl%3fz2534795095%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032743&HITNO=6&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032743&THISHREF=http://c.moreover.com/click/here.pl%3fz2534795095%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Privately Held Specialty Pharma EUSA Gets $25M Credit Facilityhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024205&HITNO=7&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024205&THISHREF=http://c.moreover.com/click/here.pl%3fz2528707615%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024205&HITNO=7&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024205&THISHREF=http://c.moreover.com/click/here.pl%3fz2528707615%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Myriad Ruling Could Have Broad Biotech Implicationshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024203&HITNO=8&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024203&THISHREF=http://c.moreover.com/click/here.pl%3fz2528706491%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024203&HITNO=8&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024203&THISHREF=http://c.moreover.com/click/here.pl%3fz2528706491%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Health Care Reform is Dead; Long Live Health Care Reform!http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020369&HITNO=9&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020369&THISHREF=http://c.moreover.com/click/here.pl%3fz2526721291%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020369&HITNO=9&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020369&THISHREF=http://c.moreover.com/click/here.pl%3fz2526721291%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioWorld: Illuminating Uveitis; Lux Seeks Luveniq Approval in U.S., Europehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020372&HITNO=10&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020372&THISHREF=http://c.moreover.com/click/here.pl%3fz2526721573%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020372&HITNO=10&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020372&THISHREF=http://c.moreover.com/click/here.pl%3fz2526721573%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioWorld: First Deal for Apeiron a Doozy: Getting up to $329M from GSKhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013086&HITNO=11&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013086&THISHREF=http://c.moreover.com/click/here.pl%3fz2523605415%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013086&HITNO=11&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013086&THISHREF=http://c.moreover.com/click/here.pl%3fz2523605415%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioWorld: First Deal for Apeiron a Doozy: Getting up to $329M from GSKhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009978&HITNO=12&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009978&THISHREF=http://c.moreover.com/click/here.pl%3fz2522184318%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009978&HITNO=12&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009978&THISHREF=http://c.moreover.com/click/here.pl%3fz2522184318%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Spectrum, TopoTarget Enter $350M Deal for Belinostathttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003350&HITNO=13&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003350&THISHREF=http://c.moreover.com/click/here.pl%3fz2519434343%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003350&HITNO=13&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003350&THISHREF=http://c.moreover.com/click/here.pl%3fz2519434343%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioWorld: XOMA Plunges on $21M Offering; Is Diabetes Drug Partner Near?http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002258&HITNO=14&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002258&THISHREF=http://c.moreover.com/click/here.pl%3fz2518824855%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002258&HITNO=14&MSIZE=102&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioWorld%20Today&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002258&THISHREF=http://c.moreover.com/click/here.pl%3fz2518824855%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: